» Articles » PMID: 17622801

Trust and Experience As Predictors of HPV Vaccine Acceptance

Overview
Journal Hum Vaccin
Date 2007 Jul 12
PMID 17622801
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Awareness of factors associated with uptake of new childhood vaccinations could help physicians focus attention on parents who are most likely to decline to help and ensure that they are fully informed before making a vaccination decision.

Aim: To examine the association between general vaccine attitudes, trust in doctors and the government, past experience with vaccination, and acceptance of HPV vaccination.

Design: School-based survey.

Setting: Questionnaires were sent through 10 schools in England.

Participants: Questionnaires were sent to 1205 mothers of 8-14 year old girls. Responses from 684 mothers were included in analyses.

Outcome Measures: Intended acceptance of prophylactic HPV vaccination.

Results: Mothers who had high trust in doctors or the government were more likely to accept the vaccine (OR = 1.35, CI: 1.22-1.50), as were those who believed their own doctor would take their vaccine concerns seriously (OR = 1.70, CI: 1.23-2.36). Mothers who had delayed (OR = 0.31, CI: 0.19-0.51), refused (OR = 0.33, CI: 0.18-0.59), or regretted (OR = 0.43, CI: 0.19-0.99) a previous paediatric vaccination were less likely to accept the HPV vaccine. The child having experienced adverse effects from a previous vaccination was not significantly associated with acceptance (OR = 0.48, CI: 0.21-1.10).

Conclusions: Past experience and trust in doctors and government were associated with differential acceptance of a new vaccine. These results suggest that doctors should listen to parents' worries about vaccination, especially parents who have previously delayed or refused vaccines. It may also be beneficial for health information to emphasize the general importance of vaccination as an effective disease prevention strategy.

Citing Articles

Examining psychological correlates of vaccine hesitancy: a comparative study between the US and Israel.

Simonovic N, Gesser-Edelsburg A, Taber J Front Public Health. 2025; 12():1480419.

PMID: 39830184 PMC: 11739079. DOI: 10.3389/fpubh.2024.1480419.


How to overcome information and communication barriers in Human Papillomavirus vaccination? A SWOT analysis based on the opinions of European family doctors in contact with young people and their parents.

Cevik H, Peker A, Gorpelioglu S, Vinker S, Ungan M Eur J Gen Pract. 2024; 30(1):2393858.

PMID: 39213042 PMC: 11370665. DOI: 10.1080/13814788.2024.2393858.


Vaccine Hesitancy among European Parents-Psychological and Social Factors Influencing the Decision to Vaccinate against HPV: A Systematic Review and Meta-Analysis.

Achimas-Cadariu T, Pasca A, Jiboc N, Puia A, Dumitrascu D Vaccines (Basel). 2024; 12(2).

PMID: 38400111 PMC: 10891840. DOI: 10.3390/vaccines12020127.


Trait and situation-specific intolerance of uncertainty predict affective symptoms during the COVID-19 pandemic.

Broos H, Dev A, Llabre M, Saab P, Timpano K J Affect Disord. 2024; 352:115-124.

PMID: 38350541 PMC: 11167600. DOI: 10.1016/j.jad.2024.02.010.


Development and validation of the Trust in Government measure (TGM).

Burns K, Brown P, Calnan M, Ward P, Little J, Betini G BMC Public Health. 2023; 23(1):2023.

PMID: 37848848 PMC: 10583387. DOI: 10.1186/s12889-023-16974-0.